134 related articles for article (PubMed ID: 36420330)
1. Can we consider soluble herpes virus entry mediator (sHVEM) as a tumor marker?
Javadzadeh SM; Tehrani M; Keykhosravi M; Mohammadian-Amiri R; Amjadi O; Hafezi N; Zaboli E; Montazeriun M; Ajami A
Caspian J Intern Med; 2022; 13(4):693-698. PubMed ID: 36420330
[TBL] [Abstract][Full Text] [Related]
2. Role of BTLA/HVEM network in development of gastric cancer.
Azarafza M; Tehrani M; Valadan R; Maleki I; Mohammad Mehdi Ghaffari-Hamedani S; Ghanadan A; Alizadeh-Navaei R; Ajami A
Hum Immunol; 2022; 83(8-9):637-644. PubMed ID: 35914980
[TBL] [Abstract][Full Text] [Related]
3. The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
Zhao Q; Zhang GL; Zhu X; Su D; Huang ZL; Hu ZX; Peng L
J Gastroenterol Hepatol; 2017 Aug; 32(8):1520-1524. PubMed ID: 27987232
[TBL] [Abstract][Full Text] [Related]
4. The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients.
Heo SK; Ju SA; Kim GY; Park SM; Back SH; Park NH; Min YJ; An WG; Nguyen TT; Kim SM; Kim BS
Exp Mol Med; 2012 Feb; 44(2):149-58. PubMed ID: 22113134
[TBL] [Abstract][Full Text] [Related]
5. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases.
Jung HW; La SJ; Kim JY; Heo SK; Kim JY; Wang S; Kim KK; Lee KM; Cho HR; Lee HW; Kwon B; Kim BS; Kwon BS
Exp Mol Med; 2003 Dec; 35(6):501-8. PubMed ID: 14749527
[TBL] [Abstract][Full Text] [Related]
6. Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.
Tsang JYS; Chan KW; Ni YB; Hlaing T; Hu J; Chan SK; Cheung SY; Tse GM
Ann Surg Oncol; 2017 Dec; 24(13):4042-4050. PubMed ID: 28612127
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
Stiles KM; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ; Krummenacher C
J Virol; 2010 Nov; 84(22):11646-60. PubMed ID: 20826693
[TBL] [Abstract][Full Text] [Related]
8. Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.
Lan X; Li S; Gao H; Nanding A; Quan L; Yang C; Ding S; Xue Y
Onco Targets Ther; 2017; 10():919-926. PubMed ID: 28243127
[TBL] [Abstract][Full Text] [Related]
9. Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.
Rapoport BL; Steel HC; Hlatshwayo N; Theron AJ; Meyer PWA; Nayler S; Benn CA; Smit T; Kwofie LLI; Heyman L; Anderson R
Front Immunol; 2022; 13():823842. PubMed ID: 35677046
[TBL] [Abstract][Full Text] [Related]
10. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R
mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863
[TBL] [Abstract][Full Text] [Related]
11. Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4.
Aldahlawi A; Basingab F; Alrahimi J; Zaher K; Pushparaj PN; Hassan MA; Al-Sakkaf K
Biomed Rep; 2023 Aug; 19(2):56. PubMed ID: 37560313
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
14. The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.
Ren S; Tian Q; Amar N; Yu H; Rivard CJ; Caldwell C; Ng TL; Tu M; Liu Y; Gao D; Ellison K; Suda K; Rozeboom L; Rivalland G; Mitchell P; Zhou C; Hirsch FR
Lung Cancer; 2018 Nov; 125():115-120. PubMed ID: 30429008
[TBL] [Abstract][Full Text] [Related]
15. Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts.
Petermann P; Rahn E; Thier K; Hsu MJ; Rixon FJ; Kopp SJ; Knebel-Mörsdorf D
J Virol; 2015 Sep; 89(18):9407-16. PubMed ID: 26136572
[TBL] [Abstract][Full Text] [Related]
16. HVEM expression contributes to tumor progression and prognosis in human colorectal cancer.
Inoue T; Sho M; Yasuda S; Nishiwada S; Nakamura S; Ueda T; Nishigori N; Kawasaki K; Obara S; Nakamoto T; Koyama F; Fujii H; Nakajima Y
Anticancer Res; 2015 Mar; 35(3):1361-7. PubMed ID: 25750286
[TBL] [Abstract][Full Text] [Related]
17. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
19. Characterization of herpes virus entry mediator as a factor linked to obesity.
Bassols J; Moreno JM; Ortega F; Ricart W; Fernandez-Real JM
Obesity (Silver Spring); 2010 Feb; 18(2):239-46. PubMed ID: 19680232
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]